Literature DB >> 3896136

Comparative pharmacokinetics of ceftazidime in fibrin clots and cardiac vegetations in rabbits with Staphylococcus aureus endocarditis.

A A McColm, D M Ryan.   

Abstract

The penetration of ceftazidime, administered in a dose of 100 mg/kg intramuscularly, into cardiac vegetations and subcutaneously implanted fibrin clots was compared in rabbits with experimental Staphylococcus aureus endocarditis. Significant pharmacokinetic differences between the time-concentration curves for the two compartments were observed. Concentrations of ceftazidime in vegetations peaked at 30 min after dosing at a level slightly lower than that in plasma and thereafter declined in parallel with concentrations in plasma throughout the 8-h sampling period. Concentrations in fibrin clots increased more slowly than those in plasma and vegetations, reaching a maximum at 120 min. This was followed by a slow elimination phase yielding concentrations in excess of concurrent plasma and vegetation levels and a greater area under the curve. These features were observed for both large (2-ml volume) and small (0.1-ml volume) clots. Contrary to previous reports, these observations suggest that fibrin clots do not provide an accurate model for predicting antibiotic concentrations in cardiac vegetations produced in endocarditis and that concentrations of antimicrobial agents in vegetations can be predicted more accurately from concomitant plasma levels.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3896136      PMCID: PMC180188          DOI: 10.1128/AAC.27.6.925

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Studies on the relationship of tissue fluid and blood levels of penicillin.

Authors:  L WEINSTEIN; G K DAIKOS; T S PERRIN
Journal:  J Lab Clin Med       Date:  1951-11

2.  Penetration of antibiotics into fibrin loci in vivo. 3. Intermittent vs. continuous infusion and the effect of probenecid.

Authors:  M Barza; J Brusch; M G Bergeron; L Weinstein
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

3.  Penetration of antibiotics into fibrin loci in vivo. I. Comparison of penetration of ampicillin into fibrin clots, abscesses, and "interstitial fluid".

Authors:  M Barza; L Weinstein
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

4.  Penetration of antibiotics into fibrin loci in vivo. II. Comparison of nine antibiotics: effect of dose and degree of protein binding.

Authors:  M Barza; T Samuelson; L Weinstein
Journal:  J Infect Dis       Date:  1974-01       Impact factor: 5.226

5.  Fibrin penetration by cephalothin and cephaloridine. An in vitro comparison.

Authors:  C J O'Connell
Journal:  J Med       Date:  1971

6.  Fibrin penetration by penicillin: in vitro simulation of intravenous therapy.

Authors:  C J O'Connell; M E Plaut
Journal:  J Lab Clin Med       Date:  1969-02

7.  A microtechnique for the determination of antibiotics in muscle.

Authors:  O Cars; S Ogren
Journal:  J Antimicrob Chemother       Date:  1981-07       Impact factor: 5.790

8.  Amphotericin B and 5-fluorocytosine penetration into blood and fibrin clots.

Authors:  E Rubinstein
Journal:  Chemotherapy       Date:  1979       Impact factor: 2.544

9.  Methicillin distribution in serum and extravascular fluid and its relevance to normal and damaged heart valves.

Authors:  F M Gengo; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

10.  Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits.

Authors:  C Carbon; A Contrepois; N Brion; S Lamotte-Barrillon
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  5 in total

Review 1.  Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditis.

Authors:  A C Cremieux; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis.

Authors:  V Joly; B Pangon; J M Vallois; L Abel; N Brion; A Bure; N P Chau; A Contrepois; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  Differential distributions in tissues and efficacies of aztreonam and ceftazidime and in vivo bacterial morphological changes following treatment.

Authors:  A Turcotte; M Simard; N J Morin; D Beauchamp; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1997-02       Impact factor: 5.191

4.  Penetration of ceftazidime into heart valves and subcutaneous and muscle tissue of patients undergoing open-heart surgery.

Authors:  U Frank; I Kappstein; E Schmidt-Eisenlohr; V Schlosser; G Spillner; M Schindler; F D Daschner
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

5.  Bactericidal interactions of a beta-lactam and beta-lactamase inhibitors in experimental Pseudomonas aeruginosa endocarditis caused by a constitutive overproducer of type Id beta-lactamase.

Authors:  A S Bayer; M Selecky; K Babel; L Hirano; J Yih; T R Parr
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.